Medicine & Life Sciences
Adenocarcinoma
16%
Biomimetics
7%
Brachytherapy
50%
Clinical Trials
9%
Clinical Trials, Phase I
8%
Confidence Intervals
19%
Costs and Cost Analysis
11%
Drug Therapy
7%
Esophagitis
8%
Head and Neck Neoplasms
9%
Human Embryonic Stem Cells
12%
Immunotherapy
34%
Ipilimumab
19%
Lung
16%
Lung Neoplasms
8%
Magnetic Resonance Spectroscopy
8%
Melanoma
7%
Neoplasm Metastasis
30%
Neoplasms
40%
Non-Small Cell Lung Carcinoma
57%
Observation
7%
Odds Ratio
11%
Organs at Risk
8%
pembrolizumab
12%
Pluripotent Stem Cells
21%
Progression-Free Survival
22%
Prostate
40%
Prostatectomy
11%
Prostatic Neoplasms
54%
Proton Therapy
11%
Radiation
43%
Radiation Pneumonitis
8%
Radiosurgery
64%
Radiotherapy
100%
Randomized Controlled Trials
8%
rat Crebbp protein
7%
Recurrence
9%
Renal Cell Carcinoma
11%
Safety
7%
Seeds
7%
Small Cell Lung Carcinoma
9%
Spine
9%
Survival
35%
Survival Rate
7%
Teratoma
12%
Therapeutics
28%
Tumor Burden
8%
Urethra
8%
Vascular Endothelial Growth Factor A
9%
Workflow
7%
Physics & Astronomy
blood cell count
5%
cancer
27%
dosage
6%
grade
6%
hazards
7%
lungs
19%
metastasis
7%
progressions
5%
radiation
6%
radiation therapy
25%
surgery
7%
therapy
10%
toxicity
10%
tumors
13%